Overestimation of HCV Prevalence Hinders Cost-Effectiveness of Universal Screening

HCV seroprevalence and antigen positivity were both low, suggesting universal birth cohort screening may not be necessary or cost-effective.

Related Keywords

Ireland ,Irish ,Kaiden Mccormick ,World Health Organization ,National Serosurveillance Program ,Vincent University Hospital ,Irish Examiner ,University Hospital ,Thcv ,Hepatitis C ,Virus ,Seroprevalence ,Antigen ,Universal Screening ,Antibody ,